Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Loretta Jacques

GLCCI1 Rs37973 Does Not Influence Treatment Response to Inhaled Corticosteroids in White Subjects With Asthma

Journal of Allergy and Clinical Immunology
AllergyImmunology
2014English

Safety and Tolerability of the Novel Inhaled Corticosteroid Fluticasone Furoate in Combination With the Β2agonist Vilanterol Administered Once Daily for 52 Weeks in Patients ≥12 Years Old With Asthma: A Randomised Trial

Thorax
PulmonaryRespiratory Medicine
2013English

Fluticasone Furoate: Once-Daily Evening Treatment Versus Twice-Daily Treatment in Moderate Asthma

Respiratory Research
PulmonaryRespiratory Medicine
2011English

Integrated Safety and Efficacy Analysis of Once-Daily Fluticasone Furoate for the Treatment of Asthma

Respiratory Research
PulmonaryRespiratory Medicine
2016English

Efficacy and Safety of Fluticasone Furoate 100 Μg Once-Daily in Patients With Persistent Asthma: A 24-Week Placebo and Active-Controlled Randomised Trial

Respiratory Medicine
PulmonaryRespiratory Medicine
2014English

Fluticasone Furoate/Vilanterol Once Daily Improves Night-Time Awakenings in Asthma Patients With Night Symptoms; Post-Hoc Analyses of Three Randomized Controlled Trials

Journal of Asthma
Child HealthAllergyPerinatologyImmunologyMedicinePediatricsPulmonaryRespiratory Medicine
2018English

Comparison of Vilanterol, a Novel Long-Acting Beta2 Agonist, With Placebo and a Salmeterol Reference Arm in Asthma Uncontrolled by Inhaled Corticosteroids

Journal of Negative Results in BioMedicine
GeneticsPharmacologyMolecular BiologyBiochemistryMedicineToxicologyPharmaceutics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy